Novo Holdings A/S - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 42 filers reported holding CYTEIR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,920,916
-79.8%
676,379
-81.5%
0.14%
-80.7%
Q2 2023$9,522,854
-91.6%
3,662,636
-7.0%
0.74%
-90.1%
Q1 2023$112,892,832
+1636.4%
3,940,4130.0%7.45%
+1734.7%
Q4 2022$6,501,681
-14.1%
3,940,4130.0%0.41%
+12.5%
Q3 2022$7,566,000
-47.7%
3,940,413
-18.6%
0.36%
-49.4%
Q2 2022$14,473,000
-20.7%
4,840,4130.0%0.71%
-26.0%
Q1 2022$18,248,000
-66.8%
4,840,4130.0%0.96%
-63.0%
Q4 2021$55,035,000
-35.2%
4,840,4130.0%2.61%
-40.7%
Q3 2021$84,949,000
-18.0%
4,840,4130.0%4.39%
-4.4%
Q2 2021$103,585,0004,840,4134.60%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,459,572$4,476,4218.93%
Novo Holdings A/S 3,940,413$112,892,8327.45%
BML Capital Management, LLC 3,146,296$5,726,2594.95%
Newtyn Management, LLC 952,947$1,734,3640.34%
Aldebaran Capital, LLC 151,239$275,2550.28%
Avidity Partners Management LP 1,764,100$3,210,6620.11%
Marquette Asset Management, LLC 67,990$123,7420.03%
TANG CAPITAL MANAGEMENT LLC 100,000$182,0000.03%
RBF Capital, LLC 117,295$213,4770.02%
CAAS CAPITAL MANAGEMENT LP 150,406$273,7390.02%
View complete list of CYTEIR THERAPEUTICS INC shareholders